AAO Welcomes FDA Clear Aligner Guidance Highlighting Direct-to-Consumer Risks

The FDA has released new guidance stating clear aligners are not authorized for direct-to-consumer sales without a prescription and dental supervision, citing increased risk of complications without professional oversight.

AAO Welcomes FDA Clear Aligner Guidance Highlighting Direct-to-Consumer Risks

Share this story

Send the public story page.

Useful takeaways from this story.

The FDA has released new guidance stating clear aligners are not authorized for direct-to-consumer sales without a prescription and dental supervision, citing increased risk of complications without...

Building the complete brief

The page is ready to read now. The fuller skim-friendly version will appear here automatically.

The useful part

The FDA has released new guidance stating clear aligners are not authorized for direct-to-consumer sales without a prescription and dental supervision, citing increased risk of complications without professional oversight.

Keep reading in the app

Open the app view to save this story, compare related coverage, and continue from the same source.

Open in app